Clinical trial
Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
NCT00485771 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- January 31, 2005
- Enrollment
- 403 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.